Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human gut metagenome

ABSTRACT: Dysfunction of the Intestinal Microbiome in Inflammatory Bowel Disease and Treatment

PROVIDER: PRJNA175224 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR579274_1.fastq.gz	Fastqsanger.gz
	SRR579274_2.fastq.gz	Fastqsanger.gz
	SRR579275_1.fastq.gz	Fastqsanger.gz
	SRR579275_2.fastq.gz	Fastqsanger.gz
	SRR579276_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 22

Similar Datasets

human gut metagenome

Project description:Human gut microbiome in inflammatory bowel disease

| PRJNA423297 | ENA

Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip.

Project description:A human gut-on-a-chip microdevice was used to coculture multiple commensal microbes in contact with living human intestinal epithelial cells for more than a week in vitro and to analyze how gut microbiome, inflammatory cells, and peristalsis-associated mechanical deformations independently contribute to intestinal bacterial overgrowth and inflammation. This in vitro model replicated results from past animal and human studies, including demonstration that probiotic and antibiotic therapies can suppress villus injury induced by pathogenic bacteria. By ceasing peristalsis-like motions while maintaining luminal flow, lack of epithelial deformation was shown to trigger bacterial overgrowth similar to that observed in patients with ileus and inflammatory bowel disease. Analysis of intestinal inflammation on-chip revealed that immune cells and lipopolysaccharide endotoxin together stimulate epithelial cells to produce four proinflammatory cytokines (IL-8, IL-6, IL-1Î², and TNF-Î±) that are necessary and sufficient to induce villus injury and compromise intestinal barrier function. Thus, this human gut-on-a-chip can be used to analyze contributions of microbiome to intestinal pathophysiology and dissect disease mechanisms in a controlled manner that is not possible using existing in vitro systems or animal models. 6 samples, 2 biological replicates for each 3 conditions.

2015-12-16 | E-GEOD-65790 | biostudies-arrayexpress

Human gut metagenome

Project description:Gut microbiome structure and metabolic activity in inflammatory bowel disease

| PRJNA400072 | ENA

human gut microbiome

Project description:The Intestinal Microbiome in Children with Inflammatory Bowel Disease and Lactose Malabsorption

| PRJNA1062375 | ENA

human gut metagenome

Project description:Pediatric Inflammatory Bowel Disease Consortium Cohort

| PRJNA297124 | ENA

Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip

Project description:A human gut-on-a-chip microdevice was used to coculture multiple commensal microbes in contact with living human intestinal epithelial cells for more than a week in vitro and to analyze how gut microbiome, inflammatory cells, and peristalsis-associated mechanical deformations independently contribute to intestinal bacterial overgrowth and inflammation. This in vitro model replicated results from past animal and human studies, including demonstration that probiotic and antibiotic therapies can suppress villus injury induced by pathogenic bacteria. By ceasing peristalsis-like motions while maintaining luminal flow, lack of epithelial deformation was shown to trigger bacterial overgrowth similar to that observed in patients with ileus and inflammatory bowel disease. Analysis of intestinal inflammation on-chip revealed that immune cells and lipopolysaccharide endotoxin together stimulate epithelial cells to produce four proinflammatory cytokines (IL-8, IL-6, IL-1β, and TNF-α) that are necessary and sufficient to induce villus injury and compromise intestinal barrier function. Thus, this human gut-on-a-chip can be used to analyze contributions of microbiome to intestinal pathophysiology and dissect disease mechanisms in a controlled manner that is not possible using existing in vitro systems or animal models.

2015-12-16 | GSE65790 | GEO

human gut metagenome

Project description:16S amplicon sequence analysis of human gut microbiome in patients with Inflammatory bowel disease (IBD)

| PRJDB6133 | ENA

human gut metagenome

Project description:Discovery of disease-adapted bacterial lineages in inflammatory bowel diseases

| PRJNA993675 | ENA

human metagenome

Project description:Longitudinal Multi’omics of the Human Microbiome in Inflammatory Bowel Disease

| PRJNA398089 | ENA

human gut metagenome

Project description:Studies of metagenomes of inflammatory bowel disease patient receiving vedolizamub therapy